Skip to content
Austin Top 50
Author:
Derm-Biome Pharmaceuticals, Inc
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
June 18, 2026